Literature DB >> 16982664

Sporadic cerebral amyloid angiopathy--an important cause of cerebral haemorrhage in older people.

Bhomraj Thanvi1, Tom Robinson.   

Abstract

Cerebral amyloid angiopathy (CAA) is an important cause of primary intracerebral haemorrhage (PICH) in older people, accounting for approximately 10% of all types of PICH. The amount of amyloid deposition in the vessels and vasculopathic changes determine the propensity to PICH. The risk factors of CAA include advanced age and the presence of certain alleles of apolipoprotein E. There are no specific clinical features of CAA-related PICH, although lobar, recurrent or multiple simultaneous haemorrhages in older patients should raise suspicion of its diagnosis. A definitive diagnosis of CAA requires pathological examination of the affected tissue. However, with modern imaging techniques, it is possible to make a diagnosis of 'probable CAA' in patients presenting with PICH. Gradient-echo magnetic resonance imaging is a sensitive, non-invasive technique for identifying small haemorrhages in life. Currently, there is no specific treatment available for CAA. Recent advances in the immunopathology and pathogenesis of CAA are expected to help in developing specific anti-amyloid therapy.

Entities:  

Mesh:

Year:  2006        PMID: 16982664     DOI: 10.1093/ageing/afl108

Source DB:  PubMed          Journal:  Age Ageing        ISSN: 0002-0729            Impact factor:   10.668


  14 in total

Review 1.  The influence of the amyloid ß-protein and its precursor in modulating cerebral hemostasis.

Authors:  William E Van Nostrand
Journal:  Biochim Biophys Acta       Date:  2015-10-27

Review 2.  The Brilliance of the Zebrafish Model: Perception on Behavior and Alzheimer's Disease.

Authors:  Avinash Shenoy; Meheli Banerjee; Archana Upadhya; Siddhi Bagwe-Parab; Ginpreet Kaur
Journal:  Front Behav Neurosci       Date:  2022-06-13       Impact factor: 3.617

3.  Unexpectedly low prevalence of intracerebral hemorrhages in sporadic cerebral amyloid angiopathy: an autopsy study.

Authors:  Johannes Attems; Florían Lauda; Kurt A Jellinger
Journal:  J Neurol       Date:  2008-01-18       Impact factor: 4.849

4.  Copper accumulation and the effect of chelation treatment on cerebral amyloid angiopathy compared to parenchymal amyloid plaques.

Authors:  Xiayoue Zhu; Tiffany W Victor; Ashwin Ambi; Joseph K Sullivan; Joshua Hatfield; Feng Xu; Lisa M Miller; William E Van Nostrand
Journal:  Metallomics       Date:  2020-02-27       Impact factor: 4.526

5.  Spontaneous upper limb monoplegia secondary to probable cerebral amyloid angiopathy.

Authors:  Ahmed-Ramadan Sadek; Nandita K Parmar; Norah-Hager Sadek; Sanjana Jaiganesh; Samer Elkhodair; Thiagarajan Jaiganesh
Journal:  Int J Emerg Med       Date:  2012-01-03

6.  Age-related comparisons of evolution of the inflammatory response after intracerebral hemorrhage in rats.

Authors:  Starlee Lively; Lyanne C Schlichter
Journal:  Transl Stroke Res       Date:  2012-03-16       Impact factor: 6.829

Review 7.  Neuroinflammation after intracerebral hemorrhage.

Authors:  Eva Mracsko; Roland Veltkamp
Journal:  Front Cell Neurosci       Date:  2014-11-20       Impact factor: 5.505

8.  Engineering theranostic nanovehicles capable of targeting cerebrovascular amyloid deposits.

Authors:  Edward K Agyare; Kristen M Jaruszewski; Geoffry L Curran; Jens T Rosenberg; Samuel C Grant; Val J Lowe; Subramanian Ramakrishnan; Anant K Paravastu; Joseph F Poduslo; Karunya K Kandimalla
Journal:  J Control Release       Date:  2014-04-13       Impact factor: 11.467

9.  Declining rates of fatal and nonfatal intracerebral hemorrhage: epidemiological trends in Australia.

Authors:  Melina Gattellari; Chris Goumas; John Worthington
Journal:  J Am Heart Assoc       Date:  2014-12-08       Impact factor: 5.501

Review 10.  Primary Multiple Simultaneous Intracerebral Hemorrhages between 1950 and 2013: Analysis of Data on Age, Sex and Outcome.

Authors:  Denchai Laiwattana; Bussara Sangsawang; Nucharee Sangsawang
Journal:  Cerebrovasc Dis Extra       Date:  2014-05-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.